Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation

Published:2021-10-20 Issue:2 Volume:57 Page:271-275
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Wang Xiaodong,Yu Uet^ORCID,Yang Chunlan,Wang Chunjing,Zhang Xiaoling,Li Yue,Li Changgang,Wen Feiqiu,Liu Sixi

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-021-01499-0.pdf

Reference12 articles.

1. Feuchtinger T, Opherk K, Bethge WA, Topp MS, Schuster FR, Weissinger EM, et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood. 2010;116:4360–7. https://doi.org/10.1182/blood-2010-01-262089. e-pub ahead of print 2010/07/14.

2. Zhao XY, Pei XY, Chang YJ, Yu XX, Xu LP, Wang Y, et al. First-line therapy with donor-derived human cytomegalovirus (HCMV)-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation. Clin Infect Dis. 2020;70:1429–37. https://doi.org/10.1093/cid/ciz368. e-pub ahead of print 2019/05/09.

3. Ljungman P, de la Camara R, Robin C, Crocchiolo R, Einsele H, Hill JA, et al. Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis. 2019;19:e260–e272. https://doi.org/10.1016/s1473-3099(19)30107-0. e-pub ahead of print 2019/06/04.

4. Pfirrmann V, Oelsner S, Rettinger E, Huenecke S, Bonig H, Merker M, et al. Cytomegalovirus-specific cytokine-induced killer cells: concurrent targeting of leukemia and cytomegalovirus. Cytotherapy. 2015;17:1139–51. https://doi.org/10.1016/j.jcyt.2015.04.011. e-pub ahead of print 2015/06/15.

5. Gupta MP, Koenig LR, Doubrovina E, Hasan A, Dahi PB, O’Reilly RJ, et al. Ocular outcomes after treatment of cytomegalovirus (CMV) retinitis using adoptive immunotherapy with CMV-specific cytotoxic T-lymphocytes. Ophthalmol Retina. 2021. https://doi.org/10.1016/j.oret.2021.04.009. e-pub ahead of print 2021/04/24.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment;Viruses;2024-09-07

2. Limited protection against early-life cytomegalovirus infection results from deficiency of cytotoxic CD8 T cells;2024-07-16

3. Efficacy and safety of adoptive T‐cell therapy in treating cytomegalovirus infections post‐haematopoietic stem cell transplantation: A systematic review and meta‐analysis;Reviews in Medical Virology;2024-06-15

4. Clinical manifestations, prognostic factors, and outcomes of adenovirus pneumonia after allogeneic hematopoietic stem cell transplantation;Virology Journal;2024-05-14

5. Mucosal T-cell responses to chronic viral infections: Implications for vaccine design;Cellular & Molecular Immunology;2024-03-08